Search research articles
Contact Us
Filters
Showing results (51-60 of 103) with videos related to
Page
of 11
Sort By:
Clinical Endocrinology
|
July 1, 1994
An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year
S L Jones, P J Trainer, L Perry, et al.
The Quarterly Journal of Medicine
|
September 1, 1992
Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemia
V M Maher, P J Trainer, A Scoppola, et al.
Growth Regulation
|
June 1, 1996
Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro
M Korbonits, J A Little, C Camacho-Hübner, et al.
European Journal of Endocrinology
|
October 3, 2001
Successful treatment of resistant acromegaly with a growth hormone receptor antagonist
W M Drake, C Parkinson, S A Akker, et al.
Clinical Endocrinology
|
October 1, 1994
Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity
J M Kirk, P J Trainer, W H Majrowski, et al.
Clinical Endocrinology
|
June 4, 2016
Proopiomelanocortin interference in the measurement of adrenocorticotrophic hormone: a United Kingdom National External Quality Assessment Service study
P J Monaghan, A Kyriacou, C Sturgeon, et al.
European Journal of Endocrinology
|
March 15, 2005
Disease activity in acromegaly may be assessed 6 weeks after discontinuation of pegvisomant
W M Drake, R A Loureiro, C Parkinson, et al.
British Journal of Cancer
|
September 1, 1999
Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy
P J Jenkins, S A Sohaib, P J Trainer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 12, 1998
Acute polyneuropathy with chronic lymphocytic leukaemia and paraproteinaemia: response to chlorambucil and prednisolone
W M Drake, J P Monson, P J Trainer, et al.
Clinical Endocrinology
|
November 27, 2015
Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours
P J Monaghan, A Lamarca, J W Valle, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 103) with videos related to
Sort By:
Page
of 11
Clinical Endocrinology
|
July 1, 1994
An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year
S L Jones, P J Trainer, L Perry, et al.
The Quarterly Journal of Medicine
|
September 1, 1992
Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemia
V M Maher, P J Trainer, A Scoppola, et al.
Growth Regulation
|
June 1, 1996
Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro
M Korbonits, J A Little, C Camacho-Hübner, et al.
European Journal of Endocrinology
|
October 3, 2001
Successful treatment of resistant acromegaly with a growth hormone receptor antagonist
W M Drake, C Parkinson, S A Akker, et al.
Clinical Endocrinology
|
October 1, 1994
Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity
J M Kirk, P J Trainer, W H Majrowski, et al.
Clinical Endocrinology
|
June 4, 2016
Proopiomelanocortin interference in the measurement of adrenocorticotrophic hormone: a United Kingdom National External Quality Assessment Service study
P J Monaghan, A Kyriacou, C Sturgeon, et al.
European Journal of Endocrinology
|
March 15, 2005
Disease activity in acromegaly may be assessed 6 weeks after discontinuation of pegvisomant
W M Drake, R A Loureiro, C Parkinson, et al.
British Journal of Cancer
|
September 1, 1999
Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy
P J Jenkins, S A Sohaib, P J Trainer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 12, 1998
Acute polyneuropathy with chronic lymphocytic leukaemia and paraproteinaemia: response to chlorambucil and prednisolone
W M Drake, J P Monson, P J Trainer, et al.
Clinical Endocrinology
|
November 27, 2015
Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours
P J Monaghan, A Lamarca, J W Valle, et al.
Page
of 11